ReviewSurgical neurology international2022
Middle meningeal artery embolization for chronic subdural hematomas. A systematic review of the literature focused on indications, technical aspects, and future possible perspectives.
Review in Surgical neurology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Comparison of middle meningeal artery embolization alone, in combination with surgery, and surgery alone for chronic subdural hematoma: a network meta-analysis of 143,590 patients.Neurosurgical review · 2025Pooled it
- Middle meningeal artery embolization for chronic subdural hematoma: a systematic review.Frontiers in neurology · 2023Pooled it
- Reinitiating antiplatelet therapy in chronic subdural hematoma: Does adjunctive middle meningeal artery embolization improve outcomes?Neurosurgical review · 2026Article
- Middle Meningeal Artery Embolization as Standalone Therapy for Chronic Subdural Hematoma with Radiological Herniation Features: A Case Report.Neurology international · 2026Article
- Chronic subdural hematoma management with MMA embolization ± surgery: Pre-existing statin therapy did not reduce recurrence.Brain & spine · 2026Article
- Middle meningeal artery embolization as a stand-alone treatment for primary and recurrent chronic subdural hematoma.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025Article
- Standalone Middle Meningeal Artery Embolization Versus Medical Management for Chronic Subdural Hematomas: A Multi-Institutional and Multinational Database Study.World neurosurgery · 2025Article
- Article
- Endovascular Embolization for Chronic Subdural Hematomas: A Literature Review of the Current Evidence.Cureus · 2025Review
- Middle meningeal artery embolization for chronic subdural hematoma.BMJ surgery, interventions, & health technologies · 2025Article
- Effectiveness of a single burr hole as a surgical technique for the management of chronic subdural hematoma: A clinical case series study.Experimental and therapeutic medicine · 2025Article
- Review
- Medical management of chronic subdural hematoma with low-dose hydrocortisone: a case series.Neurosurgical review · 2024Article
- Middle meningeal artery patency after surgical evacuation for chronic subdural hematoma.Neurosurgical review · 2024Article
- Combined pterional burr hole and coagulation of middle meningeal artery for chronic subdural hematoma.Surgical neurology international · 2024Article
- Middle Meningeal Artery Embolization for Refractory Chronic Subdural Hematoma Associated with Acute Myeloid Leukemia: A Case Report.Journal of neuroendovascular therapy · 2024Article
- Updates in traumatic brain injury management: brain oxygenation, middle meningeal artery embolization and new protocols.Trauma surgery & acute care open · 2024Review
- Chronic subdural hematoma needs to be named differently.Surgical neurology international · 2024Article
- Middle meningeal artery embolization for refractory chronic subdural hematoma in a pediatric victim of nonaccidental trauma: illustrative case.Journal of neurosurgery. Case lessons · 2023Article
- Middle meningeal artery embolisation: The review of a new treatment for chronic subdural hematomas.Surgical neurology international · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic subdural hematoma (CSDH) is one of the most common neurosurgical diseases that affect elderly and fragile patients and as a consequence, management can be challenging. Surgery represents the standard treatment; however, alternative options are under investigation. Middle meningeal artery (MMA) embolization is considered a minimally invasive treatment although with poor evidence. In this review, we tried to summarize the findings about MMA embolization as a treatment for a CSDH to provide a useful guidance for clinical practice and for future speculative aspects. Methods: Literature review on PubMed until March 2021 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement. We conducted a research on PubMed with a various combinations of the keywords "CSDH" and "middle meningeal artery" and "embolization," "refractory subdural hematoma," and then we reviewed the references of the relevant studies as additional source of eligible articles. Results: Among the 35 studies eligible for this review, 22 were case series, 11 were case reports, one was a technical note, and 1 was a randomized trial. A total of 746 patients were found in the literature. Failure rate of MMA embolization was between 3.9 and 8.9% of the cases according the indication to treat CSDH (upfront vs. after surgery). Conclusion: The global impression deriving from the data available and the literature is that MMA embolization is a safe procedure with very low complications and with a low failure rate, both when associated with surgery or in case of a standalone treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.